The trigger for the incident came from a sudden announcement after the market on Tuesday: Andrew Witty, the CEO who had been at the helm for many years, suddenly announced his resignation, and the company withdrew its previously issued 2025 financial guidance on the grounds that "the surge in medical demand led to a sudden change in the operating environment". This move triggered a violent market shock, and the stock price plunged the next day.
Joanna Gajuk, an analyst at Bank of America, pointed out in the research report that the management earthquake directly disrupted the strategic deployment of United Health. She cut her rating on the company from "buy" to "neutral" and slashed her price target from $560 to $350, a 37.5% decrease. The analyst predicts that UnitedHealth's EPS in 2025 is expected to shrink by 10%-20% compared with the previous forecast, and the downward adjustment will be as high as 21%-29% compared with the initial long-term target.
The research report particularly emphasized that the decision to revoke the performance guidance reflects two deep hidden worries: First, the management lacks judgment basis on the sustainability and coverage of rising medical expenses, and second, the need to reserve sufficient time for the new CEO to reformulate the strategic plan. It is worth noting that United Health revealed in the conference call that it is planning to formulate a new bidding strategy in the next few months, with the goal of restoring an operating profit margin of 3%-5% in the medical insurance advantage plan (MA) sector, but this may come at the expense of stagnant or even loss of membership growth.
For the industry impact that the market is focused on, Gajuk believes that competitorsHamenna(HUM.US)' s situation does not yet pose a systemic risk. She analyzed that the current challenges faced by Harmena are more due to the company's own governance problems, and the lightning departure of the CEO of United Health is more like a signal of internal management disorder than a sign of headwinds in the whole health management industry.
This sudden management earthquake not only exposed the vulnerability of health insurance giants under the pressure of medical inflation, but also triggered the market to re-examine the valuation system of the medical sector. As the 2025 medical insurance bidding season approaches, the industry may usher in a new round of strategic adjustment cycle.
Comments